June 17 (Reuters) - NMT Medical Inc said its device to prevent stroke in patients with a congenital heart condition failed to meet its main goal in a trial, sending its shares plunging 80 percent to a ...

Adeno-associated virus (AAV)–mediated gene therapy was one of the focal points of this year's Muscular Dystrophy Association conference. Here, Barry Byrne, MD, PhD, University of Florida, speaks to ...

Nowadays, people spend most of their time seated, whether they’re hard at work at their location-neutral job, playing video games, or using the various social media platforms to interact or visit ...

New data suggest motor function improves with amifampridine. New phase 2 data for the spinal muscular atrophy (SMA) therapy amifampridine (Ruzurgi) suggests the drug is safe and effective at improving ...

Objective: Positive influence of electrostimulation on the healing process of the gluteal decubital ulcers. Setting: Department of Neurosurgery, University of Cologne, Germany. Method: The present ...

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen’s UPLIZNA ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...